These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Kynurenic acid synthesis in cerebral cortical slices of rats with progressing symptoms of thioacetamide-induced hepatic encephalopathy. Saran T; Hilgier W; Urbańska EM; Turski WA; Albrecht J J Neurosci Res; 2004 Feb; 75(3):436-40. PubMed ID: 14743457 [TBL] [Abstract][Full Text] [Related]
10. Long-term exposure to nicotine markedly reduces kynurenic acid in rat brain--in vitro and ex vivo evidence. Zielińska E; Kuc D; Zgrajka W; Turski WA; Dekundy A Toxicol Appl Pharmacol; 2009 Oct; 240(2):174-9. PubMed ID: 19616570 [TBL] [Abstract][Full Text] [Related]
11. Ketogenic diet increases concentrations of kynurenic acid in discrete brain structures of young and adult rats. Żarnowski T; Chorągiewicz T; Tulidowicz-Bielak M; Thaler S; Rejdak R; Żarnowski I; Turski WA; Gasior M J Neural Transm (Vienna); 2012 Jun; 119(6):679-84. PubMed ID: 22200857 [TBL] [Abstract][Full Text] [Related]
12. A systemically-available kynurenine aminotransferase II (KAT II) inhibitor restores nicotine-evoked glutamatergic activity in the cortex of rats. Koshy Cherian A; Gritton H; Johnson DE; Young D; Kozak R; Sarter M Neuropharmacology; 2014 Jul; 82():41-8. PubMed ID: 24647121 [TBL] [Abstract][Full Text] [Related]
13. L-cysteine sulphinate, endogenous sulphur-containing amino acid, inhibits rat brain kynurenic acid production via selective interference with kynurenine aminotransferase II. Kocki T; Luchowski P; Luchowska E; Wielosz M; Turski WA; Urbanska EM Neurosci Lett; 2003 Jul; 346(1-2):97-100. PubMed ID: 12850557 [TBL] [Abstract][Full Text] [Related]
14. Influence of Cyclooxygenase-2 Inhibitors on Kynurenic Acid Production in Rat Brain in Vitro. Zakrocka I; Targowska-Duda KM; Wnorowski A; Kocki T; Jóźwiak K; Turski WA Neurotox Res; 2019 Jan; 35(1):244-254. PubMed ID: 30178287 [TBL] [Abstract][Full Text] [Related]
15. FK506 attenuates 1-methyl-4-phenylpyridinium- and 3-nitropropionic acid-evoked inhibition of kynurenic acid synthesis in rat cortical slices. Luchowska E; Luchowski P; Wielosz M; Turski WA; Urbanska EM Acta Neurobiol Exp (Wars); 2003; 63(2):101-8. PubMed ID: 12926536 [TBL] [Abstract][Full Text] [Related]
16. Age dependency of inhibition of alpha7 nicotinic receptors and tonically active N-methyl-D-aspartate receptors by endogenously produced kynurenic acid in the brain. Alkondon M; Pereira EF; Eisenberg HM; Kajii Y; Schwarcz R; Albuquerque EX J Pharmacol Exp Ther; 2011 Jun; 337(3):572-82. PubMed ID: 21270133 [TBL] [Abstract][Full Text] [Related]
17. Memantine and the Kynurenine Pathway in the Brain: Selective Targeting of Kynurenic Acid in the Rat Cerebral Cortex. Kloc R; Urbanska EM Cells; 2024 Aug; 13(17):. PubMed ID: 39272996 [TBL] [Abstract][Full Text] [Related]
18. High Concentration of Ketone Body β-Hydroxybutyrate Modifies Synaptic Vesicle Cycle and Depolarizes Plasma Membrane of Rat Brain Synaptosomes. Voronina PP; Adamovich KV; Adamovich TV; Dubouskaya TG; Hrynevich SV; Waseem TV; Fedorovich SV J Mol Neurosci; 2020 Jan; 70(1):112-119. PubMed ID: 31643037 [TBL] [Abstract][Full Text] [Related]
19. Increased kynurenic acid levels and decreased brain kynurenine aminotransferase I in patients with Down syndrome. Baran H; Cairns N; Lubec B; Lubec G Life Sci; 1996; 58(21):1891-9. PubMed ID: 8637415 [TBL] [Abstract][Full Text] [Related]
20. Modulation by kynurenine of extracellular kynurenate and glutamate in cerebral cortex of rats with acute liver failure. Hilgier W; Kocki T; Obara-Michlewska M; Turski WA; Oja SS; Saransaari P; Albrecht J Pharmacol Rep; 2014 Jun; 66(3):466-70. PubMed ID: 24905525 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]